BG109430A - FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION - Google Patents

FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION

Info

Publication number
BG109430A
BG109430A BG109430A BG10943006A BG109430A BG 109430 A BG109430 A BG 109430A BG 109430 A BG109430 A BG 109430A BG 10943006 A BG10943006 A BG 10943006A BG 109430 A BG109430 A BG 109430A
Authority
BG
Bulgaria
Prior art keywords
fluconazole
capsules
improved release
active ingredient
fluconazole capsules
Prior art date
Application number
BG109430A
Other languages
Bulgarian (bg)
English (en)
Inventor
Pal Fekete
Judit Virgula
Eva Furdyga
Huszar Magdolna Leventiszne
Imre Klebovich
Nemes Katalin Baloghne
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of BG109430A publication Critical patent/BG109430A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG109430A 2003-07-02 2006-02-02 FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION BG109430A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0302030A HU227142B1 (en) 2003-07-02 2003-07-02 Capsule of improved release containing fluconazole

Publications (1)

Publication Number Publication Date
BG109430A true BG109430A (en) 2006-11-30

Family

ID=89981480

Family Applications (1)

Application Number Title Priority Date Filing Date
BG109430A BG109430A (en) 2003-07-02 2006-02-02 FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION

Country Status (10)

Country Link
EP (1) EP1648451A2 (cs)
CN (1) CN1812783A (cs)
BG (1) BG109430A (cs)
CZ (1) CZ200657A3 (cs)
EA (1) EA008585B1 (cs)
HU (1) HU227142B1 (cs)
PL (1) PL380995A1 (cs)
SK (1) SK50132006A3 (cs)
UA (1) UA82532C2 (cs)
WO (1) WO2005002553A2 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
GB0900786D0 (en) * 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
MD3971C2 (ro) * 2009-04-29 2010-06-30 Дмитрий СКУРТУ Scaun-trenajor
KR20140053158A (ko) 2011-07-29 2014-05-07 그뤼넨탈 게엠베하 즉시 약물 방출을 제공하는 탬퍼-저항성 정제
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
WO2015004245A1 (en) 2013-07-12 2015-01-15 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105616378A (zh) * 2014-10-31 2016-06-01 康普药业股份有限公司 一种氟康唑胶囊及其制备方法
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
CN113230236A (zh) * 2021-04-29 2021-08-10 山东优杰生物科技有限公司 祛除灰指甲草本贴及其制备方法
CN117137878A (zh) * 2023-07-16 2023-12-01 海南林恒制药股份有限公司 一种氟康唑胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US6214386B1 (en) * 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
CN1156461C (zh) * 1999-03-24 2004-07-07 R·P·希拉技术股份有限公司 改良的水溶性药物制剂
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
RU2201230C1 (ru) * 2001-12-24 2003-03-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство флузол, обладающее противогрибковым действием

Also Published As

Publication number Publication date
WO2005002553A2 (en) 2005-01-13
EA008585B1 (ru) 2007-06-29
CN1812783A (zh) 2006-08-02
UA82532C2 (uk) 2008-04-25
EP1648451A2 (en) 2006-04-26
PL380995A1 (pl) 2007-04-16
HU0302030D0 (en) 2003-09-29
CZ200657A3 (cs) 2006-04-12
WO2005002553A3 (en) 2005-03-24
HU227142B1 (en) 2010-08-30
EA200600085A1 (ru) 2006-08-25
SK50132006A3 (sk) 2006-05-04
HUP0302030A2 (hu) 2005-03-29

Similar Documents

Publication Publication Date Title
MY147641A (en) Fast release paracetamol tablets
BG109430A (en) FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION
IL187475A (en) A form of oral administration containing one population of micro-particles to release a variable of at least one active anesthetic and a second population of micro-particles containing at least one depressant and their use
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
MY142067A (en) Xanthine derivatives as selective hm74a agonists, processes for the manufacture of said derivatives, formulations comprising these derivatives, and their use in the treatment of diseases where under-activation of the hm74a receptor contributes to the disease
EA200500909A1 (ru) Модифицированное высвобождение фармацевтической композиции
HRP20090194T1 (hr) Suha granulirana kompozicija koja sadrži emtricitabin i tenofovir df
IL181524A (en) Heterocyclic compounds, pharmaceuticals containing them and their use in the preparation of drugs
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
AU2003274681A8 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
IL181445A0 (en) Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium selective modulators
UA88300C2 (ru) Гидрогелевые композиции, которые содержат интерферон
AR077411A2 (es) Forma de dosificacion farmaceutica solida, con lopinavir y ritonavir, y proceso para su preparacion.
MX2009008952A (es) Microesferas que comprenden una matriz de sustancia activa resistente a jugo gastrico.
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
WO2008073282A3 (en) Ph sensitive matrix formulation
WO2009060608A1 (ja) Ｓｄｆ－１を含有してなる徐放性組成物
TW200731971A (en) Solid preparation
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
WO2005007137A8 (de) Ambroxolhaltige tabletten
DE60331648D1 (de) Puffende orale darreichungsformen
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
WO2008133731A3 (en) Rapidly disintegrating low friability tablets comprising silica materials
GB2443793B (en) Product, method of manufacture and use
WO2011090725A3 (en) Gastroretentive solid oral dosage forms with swellable hydrophilic polymer